Boehringer Ingelheim International Gmbh

Viropharma Incorporated

Sprout Pharmaceuticals, Inc.

Letavis Ab

Boehringer Ingelheim Pharma Gmbh & Co Kg

Mihaela Pop

Peter Sieger

Jaroslaw Mazurek

Mimoun Lamkadmi

Eugene C Amparo

Cristina Stoica

Stéphanie Houdayer Mulder

Paula Vasilichia Bulieris

Ingemar Pongratz

Victor Fruth-Oprisan

Raul-Augustin Mitran

Houdayer Stéphanie Mulder

The present document is directed to co-crystals of resveratrol and/or curcumin with piperazine and their use in medicine and/or as food and feed supplements.

Resveratrol-piperazine co-crystals

The present invention relates to new crystalline salt forms of flibanserine which have valuable pharmacological properties, to a process for their manufacture, to pharmaceutical formulations containing them and to their use as medicament.

Salts

The invention relates to novel crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-(&#x3b2;-L-ribofuranosyl)-1H-benzimidazole (Maribavir), pharmaceutical compositions thereof and their use in medical therapy.

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-&#x3b2;-L-ribofuranosyl-1H-benzimidazole

The invention relates to a new crystalline forms of tiotropium bromide, processes for preparing them and their use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.

Crystalline forms of tiotropium bromide

Growing community of inventors

Amsterdam, Netherlands

Mihaela Pop